rs199830550
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000219204.8(ARL2BP):c.207+1G>A variant causes a splice donor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000815 in 1,522,354 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
ENST00000219204.8 splice_donor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARL2BP | NM_012106.4 | c.207+1G>A | splice_donor_variant | ENST00000219204.8 | NP_036238.1 | |||
LOC124903697 | XR_007065082.1 | n.1417C>T | non_coding_transcript_exon_variant | 2/2 | ||||
ARL2BP | XM_047433883.1 | c.111+1G>A | splice_donor_variant | XP_047289839.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARL2BP | ENST00000219204.8 | c.207+1G>A | splice_donor_variant | 1 | NM_012106.4 | ENSP00000219204 | P1 | |||
ARL2BP | ENST00000563234.1 | c.199+1G>A | splice_donor_variant | 2 | ENSP00000454237 | |||||
ARL2BP | ENST00000562023.5 | c.101-1136G>A | intron_variant | 3 | ENSP00000457465 | |||||
PLLP | ENST00000564376.1 | n.321-18C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000121 AC: 26AN: 215538Hom.: 0 AF XY: 0.0000940 AC XY: 11AN XY: 117078
GnomAD4 exome AF: 0.0000861 AC: 118AN: 1370214Hom.: 0 Cov.: 20 AF XY: 0.0000820 AC XY: 56AN XY: 682746
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74320
ClinVar
Submissions by phenotype
ARL2BP-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 25, 2023 | The ARL2BP c.207+1G>A variant is predicted to disrupt the GT donor site and interfere with normal splicing. This variant has been reported in the homozygous state in individuals with retinal dystrophy (Patient G005193 in Table S2, Carss et al. 2017. PubMed ID: 28041643; Fiorentino et al. 2018. PubMed ID: 30210231; Supplementary Table 2 in Turro et al. 2020. PubMed ID: 32581362). This variant was reported in the homozygous state in a male patient with retinal pigmentosa and abnormal sperm morphology (P1 in Moye et al. 2019. PubMed ID: 31425546). Functional studies showed that this variant led to skipping of exon 3 (Fiorentino et al. 2018. PubMed ID: 30210231; Moye et al. 2019. PubMed ID: 31425546). This variant is reported in 0.049% of alleles in individuals of European (Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/16-57282556-G-A). Variants that disrupt the consensus splice donor site in ARL2BP are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Retinitis pigmentosa with or without situs inversus Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 27, 2024 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 03, 2023 | This sequence change affects a donor splice site in intron 3 of the ARL2BP gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (rs199830550, gnomAD 0.04%). Disruption of this splice site has been observed in individuals with inherited retinal dystrophy (PMID: 27790702, 28041643, 30210231, 32581362). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 437946). Studies have shown that disruption of this splice site results in skipping of exon 3 and introduces a premature termination codon (PMID: 30210231). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. - |
Retinal dystrophy Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | NIHR Bioresource Rare Diseases, University of Cambridge | Jan 01, 2015 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at